Article Text

Download PDFPDF
Varicella vaccination in a patient with recurrent genital herpes
  1. Bret Palmer1,2
  1. 1 Florey Clinic, Royal Berkshire NHS Foundation Trust, Reading RG1 5LE, UK
  2. 2 The Riverside Clinic, Royal United Hospital, James St West, Bath BA1 2BT, UK
  1. Correspondence to Dr Bret Palmer, Florey Clinic, Royal Berkshire NHS Foundation Trust, Reading RG1 5LE, UK; bret.palmer3{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Dear Editor,

A 26-year-old woman consented to take part in an ongoing, case–control study investigating whether varicella-zoster virus (VZV) IgG titres are associated with the likelihood of experiencing symptomatic Herpes Simplex Virus (HSV) infection. The study is to inform future research on using vaccination against VZV as a pathway to a possible HSV functional cure. She had an 8-year history of recurring genital herpes, with an average of two episodes per month. At the last recurrence, a genital swab was …

View Full Text


  • Handling editor Anna Maria Geretti

  • Twitter @Bret_S_Palmer

  • Contributors BP conceived and designed the work as well as drafted and revised it critically for important intellectual content. BP will be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

  • Funding The VZV case–control study was funded by the Florey Clinic, Reading. The author has received no financial contribution for this work.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.